Syntese, a Ferring Company

Syntese, a Ferring Company, stands as a prominent name in pharmaceutical manufacturing, recognized as a leading producer of Mesalazine/Mesalamine, a vital active pharmaceutical ingredient (API) used in Inflammatory Bowel Disease (IBD) treatment. With over 30 years of experience in product and process development, Syntese guarantees products of the highest quality alongside extensive R&D support and comprehensive regulatory compliance.

Syntese, a Ferring Company has developed its own unique chemical synthesis method for producing 5-ASA, implementing it for full-scale production under stringent cGMP standards. The company’s commitment to quality is further underscored by its possession of a Certificate of Suitability, European DMF, Canadian DMF, US DMF, and FDA approval. Syntese’s dedication to safety and environmental responsibility is demonstrated through Annual Environmental Reports and the County Environmental Award. The primary address of Syntese, a Ferring Company is Industriholmen 11-13, 2650 Hvidovre, DK.

Mesalazine is manufactured in multi-tons per year at the company’s highly automated production facility in Hvidovre, near Copenhagen. Syntese, a Ferring Company consistently delivers exceptional products and services to meet the evolving needs of the pharmaceutical industry. We invite the manager of Syntese, a Ferring Company, to create a customized and exclusive company showcase and product listing on our platform.